C-Met function requires n-linked glycosylation modification of pro-Met

Journal of Cellular Biochemistry

Volumn 114, Issue 4, 2013, Pages 816-822

  Chen, Run ^a   Li, Juan ^a   Feng, Chun Hong ^a   Chen, Shao Kun ^a   Liu, You Ping ^a   Duan, Chun Yan ^a   Li, Hong ^a   Xia, Xian Ming ^a   He, Tao ^a   Wei, Mei ^a   Dai, Rong Yang ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

c Met; GLYCOSYLATION; PHOSPHORYLATION; pro Met

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ARTICLE; CYTOPLASM; ENDOPLASMIC RETICULUM STRESS; GLYCOSYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION;

CELL LINE, TUMOR; CELL MEMBRANE; CYTOPLASM; ENDOPLASMIC RETICULUM STRESS; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION; HEPATOCYTE GROWTH FACTOR; HUMANS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PIPERIDINES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MET; PYRIDINES; TUNICAMYCIN;

EID: 84874229642     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24420     Document Type: Article

References (20)

1. Ambasta RK, Ai X, Emerson CP, Jr., 2007. Quail Sulf1 function requires asparagine-linked glycosylation. J Biol Chem 282: 34492-34499.
2. Bellon SF, Kaplan-Lefko P, Yang Y, Zhang Y, Moriguchi J, Rex K, Johnson CW, Rose PE, Long AM, O'Connor AB, Gu Y, Coxon A, Kim TS, Tasker A, Burgess TL, Dussault I,. 2008. c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. J Biol Chem 283: 2675-2683.
3. Benvenuti S, Comoglio PM,. 2007. The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 213: 316-325.
4. Boccaccio C, Comoglio PM,. 2006. Invasive growth: A MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 6: 637-645.
5. Branza-Nichita N, Lazar C, Dwek RA, Zitzmann N,. 2004. Role of N-glycan trimming in the folding and secretion of the pestivirus protein E(rns). Biochem Biophys Res Commun 319: 655-662.
6. Dai R, Li J, Fu J, Chen Y, Yu L, Zhao X, Qian Y, Zhang H, Chen H, Ren Y, Su B, Luo T, Zhu J, Wang H,. 2012. Disturbance of Ca2+ homeostasis converts pro-Met into non-canonical tyrosine kinase p190MetNC in response to endoplasmic reticulum stress in MHCC97cells. J Biol Chem 287: 14586-14597.
7. Dai RY, Chen Y, Fu J, Dong LW, Ren YB, Yang GZ, Qian YW, Cao J, Tang SH, Yang SL, Wang HY,. 2009. p28GANK inhibits endoplasmic reticulum stress-induced cell death via enhancement of the endoplasmic reticulum adaptive capacity. Cell Res 19: 1243-1257.
8. Desiderio MA,. 2007. Hepatocyte growth factor in invasive growth of carcinomas. Cell Mol Life Sci 64: 1341-1354.
9. Eisele F, Wolf DH,. 2008. Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1. FEBS Lett 582: 4143-4146.
10. Ferracini R, Longati P, Naldini L, Vigna E, Comoglio PM,. 1991. Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. J Biol Chem 266: 19558-19564.
11. Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, Fiaccavento R, Carotenuto F, De Vito P, Baldini PM, Prat M, Di Nardo P,. 2006. Hepatocyte growth factor effects on mesenchymal stem cells: Proliferation, migration, and differentiation. Stem Cells 24: 23-33.
12. Gay B, Suarez S, Weber C, Rahuel J, Fabbro D, Furet P, Caravatti G, Schoepfer J,. 1999. Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motility. J Biol Chem 274: 23311-23315.
13. Giordano S, Di Renzo MF, Narsimhan RP, Cooper CS, Rosa C, Comoglio PM,. 1989. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 4: 1383-1388.
14. Hebert DN, Molinari M,. 2007. In and out of the ER: Protein folding, quality control, degradation, and related human diseases. Physiol Rev 87: 1377-1408.
15. Jeffers M, Fiscella M, Webb CP, Anver M, Koochekpour S, Vande Woude GF,. 1998. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci USA 95: 14417-14422.
16. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B, Vande Woude GF,. 1997. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 94: 11445-11450.
17. Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, Miller M, Lubensky I, Neumann HP, Brauch H, Decker J, Vocke C, Brown JA, Jenkins R, Richard S, Bergerheim U, Gerrard B, Dean M, Linehan WM, Zbar B,. 1999. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18: 2343-2350.
18. Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E,. 1997. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 25: 862-866.
19. Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM,. 2001. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 153: 1023-1034.
20. You H, Ding W, Dang H, Jiang Y, Rountree CB,. 2011. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 54: 879-889.